Prospective clinical study on efficacy and tolerability (examination of gastrointestinal symptoms) of mineral and bone disorder of Sucroferric oxyhydroxide in hemodialysis patients
Not Applicable
- Conditions
- Hyperphosphatemia in chronic kidney disease patients on hemodialysis
- Registration Number
- JPRN-UMIN000033634
- Lead Sponsor
- kitasao University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who conflict with one of the following are excluded from this study. 1)Patients who have a history of hypersensitivity to the ingredients of sucroferric oxyhydroxide 2)Patients falling under the careful administration of sucroferric oxyhydroxide 3)Patients taking phosphorus binder drugs other than precipitated calcium carbonate 4)Patients taking Lubiprostone 5)Patients receiving antibiotics 6)patients who judged that the doctor in charge is not appropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the change of serum phosphorus concentration, corrected calcium concentration, serum intact-PTH concentration at the start and after 3 months
- Secondary Outcome Measures
Name Time Method 1)State of occurrence of side effects 2)Clinical examination (iron related examination) 3)Defecation status 4)Medication status